University of Alberta - Clinical Islet Transplant Program
Welcome,         Profile    Billing    Logout  
 7 Trials 
11 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Shapiro, James
NCT03182426: Stem Cell Mobilization (Plerixafor) and Immunologic Reset in Type 1 Diabetes (T1DM)

Completed
1/2
22
Canada
Plerixafor, Mozobil, Alemtuzumab, Lemtrada, Anakinra, Kineret, Etanercept, Enbrel, Liraglutide, Victoza
University of Alberta, Alberta Innovates Health Solutions
Diabetes Mellitus, Type 1
07/24
07/24
NCT03089840: Normothermic Liver Preservation Trial

Completed
1/2
106
Canada
OrganOx metra
University of Alberta
End Stage Liver Disease, Liver Diseases
07/24
07/24
NCT03444064: PolyTreg Immunotherapy in Islet Transplantation

Completed
1
11
Canada
PolyTregs, Ex vivo Expanded Autologous CD4+CD127lo/-CD25+ Polyclonal Regulatory T cells
University of Alberta, Diabetes Research Institute Foundation, Liana's Dream Foundation, Juvenile Diabetes Research Foundation, Alberta Diabetes Institute
Diabetes, Diabetes Mellitus, Type 1
08/24
12/24
NCT05073302: Device-Less Technique in Islet Transplantation

Recruiting
1
5
Canada
Implantation of Nylon catheter (Device-less sentinel unit)
University of Alberta, Juvenile Diabetes Research Foundation
Type 1 Diabetes
01/25
01/25
cePolyTregs, NCT05349591: CePolyTregs in Islet Transplantation

Active, not recruiting
1
11
Canada
cePolytreg
University of Alberta, Juvenile Diabetes Research Foundation, Juvenile Diabetes Research Foundation Canadian Clinical Trial Network
Diabetes Type1
05/26
05/26
NCT03073577: Islet Transplantation Using PKX-001

Recruiting
1
6
Canada
Antiaging Glycopeptide, PKX-001, AAGP
University of Alberta, ProtoKinetix Inc.
Type 1 Diabetes Mellitus
03/25
03/25
Senior, Peter
TRANSCEND-T2D-2, NCT06260722: Effect of Retatrutide Compared With Semaglutide in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Metformin With or Without SGLT2 Inhibitor

Recruiting
3
1250
Canada, US, RoW
Retatrutide, LY3437943, Semaglutide
Eli Lilly and Company
Diabetes Mellitus, Type 2
12/26
03/27
SUGARNSALT, NCT06217302: Sotagliflozin to Slow Kidney Function Decline in Persons with Type 1 Diabetes and Diabetic Kidney Disease

Recruiting
3
150
Canada, US
Sotagliflozin, INPEFA, Placebo
Alessandro Doria, Canadian Institutes of Health Research (CIHR), The Kidney Foundation of Canada, The Cleveland Clinic, University of Michigan, University of Colorado, Denver, Northwestern University, Washington University School of Medicine, State University of New York - Upstate Medical University, Providence Medical Research Center, Stanford University, Montefiore Medical Center, University of Toronto, University Health Network, Toronto, University of Calgary, University of Alberta, University of British Columbia, Institut de Recherches Cliniques de Montreal, LMC Diabetes & Endocrinology Ltd., Joslin Diabetes Center, Lexicon Pharmaceuticals, DexCom, Inc., University of Washington, Breakthrough T1D
Diabetic Nephropathies, Kidney Failure, Chronic, Diabetes Mellitus Type 1, Heart Failure
12/28
05/29
NCT06474598: An Adaptive Design Study of MTX228

Recruiting
2
24
Canada
MTX228, Tolimidone, DEXCOM G6
University of Alberta
Type 1 Diabetes Mellitus
10/26
12/27
NCT05073302: Device-Less Technique in Islet Transplantation

Recruiting
1
5
Canada
Implantation of Nylon catheter (Device-less sentinel unit)
University of Alberta, Juvenile Diabetes Research Foundation
Type 1 Diabetes
01/25
01/25
NCT03720197: Registry of Patients Living With Type 1 Diabetes

Recruiting
N/A
6000
Canada
Online questionnaire - Phase 1, Online questionnaire - Phase 2, Online questionnaire - Phase 3, Food questionnaire, Pedometer, Waist circumference, Blood and urine tests, List of medications, Continuous glucose monitor
Institut de Recherches Cliniques de Montreal
Type 1 Diabetes Mellitus
03/26
03/26

Download Options